Multiplexed Antibody Characterization

The discovery and development of antibody therapeutics is a time-intensive and costly process that involves screening of large candidate libraries, functional characterization of lead molecules in vitro, and preclinical testing in animal models of efficacy andtoxicity. This case study describes how XOMA is incorporating IntelliCyt’s screening platform to drive the success of their antibody engineering efforts.